Genetic Predisposition [orga]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
Therapies [ftcn]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Background [cnce]    
Currently [tmco]    
Set [menp]    
New [tmco]    
Standard [qlco]    
Advance [qlco]    
Hepatocellular carcinoma [neop]    
Suggest [idcn]    
Asian [popg]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Increase [qnco]    
susceptibilities [clna]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
Relate [orch]    
To [qlco]    
Therapies [ftcn]    
Author [prog]    
investigate [ftcn]    
Associate [menp]    
Induce [ftcn]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
Genetic Polymorphism [genf]    
Korean [popg]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Method [inpr]    
Prospective Cohort Study [resa]    
Author [prog]    
Consecutive [qlco]    
patient [podg]    
Intermediate [spco]    
Stage [tmco]    
Hepatocellular carcinoma [neop]    
>5 [qnco]    
Center [spco]    
Korea [geoa]    
patient [podg]    
Receive [qlco]    
mg% [qnco]    
Twice daily [tmco]    
Combination [qlco]    
Transarterial Chemoembolization [topp]    
Genotype [lbpr]    
Perform [ftcn]    
% total [qnco]    
Single Nucleotide Polymorphism [nusq]    
Candidate Gene [gngm]    
Minor [popg]    
Allele Frequency [qnco]    
>5 [qnco]    
Serum [bdsu]    
Level [qlco]    
Measurable [qlco]    
Using [ftcn]    
Immunosorbent Assays, Enzyme-Linked [lbpr]    
Therapies [ftcn]    
1 Month [tmco]    
Therapies [ftcn]    
Result [ftcn]    
median [spco]    
treatment [ftcn]    
period [tmco]    
month [tmco]    
55 [inpr]    
patient [podg]    
Induce [ftcn]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
include [ftcn]    
Grade 1 [qlco]    
Reaction [ftcn]    
patient [podg]    
grade 2 [inpr]    
Reaction [ftcn]    
patient [podg]    
Grade III [qlco]    
Reaction [ftcn]    
patient [podg]    
Single Nucleotide Polymorphism [nusq]    
familial [famg]    
Polypeptide [aapp]    
A9 [bpoc]    
UGT1A9 [gngm]    
Associated [qlco]    
development [phsf]    
High grade [qlco]    
grade 2 [inpr]    
<3 [qnco]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
univariate analysis [resa]    
Multivariate Analysis [qnco]    
Single Nucleotide Polymorphism [nusq]    
odd ratio [qnco]    
odd ratio [qnco]    
UGT1A9 [gngm]    
odd ratio [qnco]    
Identifiable [qlco]    
Independence [idcn]    
Risk factor [qnco]    
development [phsf]    
High grade [qlco]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
Serum [bdsu]    
Level [qlco]    
Measurable [qlco]    
1 Month [tmco]    
Therapies [ftcn]    
Correlated [qlco]    
development [phsf]    
High grade [qlco]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
odd ratio [qnco]    
<3 [qnco]    
Conclusion [idcn]    
*Difference [qnco]    
Incidence [qnco]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
cause [ftcn]    
ethnic differences [fndg]    
Genetic Polymorphism [genf]    
UGT1A9 gene [gngm]    
Expression [topp]    
Serum [bdsu]    
Therapies [ftcn]    
Cancer [neop]    
[c] [qnco]    
American Cancer Society [pros]    
